TAIHO ONCOLOGY ANNOUNCES UPDATED EFFICACY AND SAFETY DATA FOR FUTIBATINIB IN CHO
- This topic has 0 replies, 1 voice, and was last updated 2 years, 5 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
TAIHO ONCOLOGY ANNOUNCES UPDATED EFFICACY AND SAFETY DATA FOR FUTIBATINIB IN CHOLANGIOCARCINOMA AT 2022 ASCO ANNUAL MEETING
https://www.taihooncology.com/us/news/2022-06-03_asco_2022_press_release/
Thanks to TAIHO ONCOLOGY, INC for this piece.
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.